Electromedical Technologies, Inc. (EMED)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Mar 14, 2025, 9:54 AM EST
EMED Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 0.92 | 1.35 | 1.15 | 0.91 | 0.74 | 0.83 | Upgrade
|
| Revenue Growth (YoY) | -35.09% | 17.30% | 26.72% | 22.96% | -11.06% | 22.85% | Upgrade
|
| Cost of Revenue | 0.23 | 0.3 | 0.26 | 0.2 | 0.19 | 0.24 | Upgrade
|
| Gross Profit | 0.69 | 1.05 | 0.89 | 0.71 | 0.54 | 0.59 | Upgrade
|
| Selling, General & Admin | 1.47 | 2.44 | 2.16 | 4.13 | 3.51 | 2.14 | Upgrade
|
| Research & Development | -0.06 | 0.23 | 0.09 | 0.22 | 0.03 | - | Upgrade
|
| Other Operating Expenses | 0.3 | 0.44 | 0.24 | 0.16 | 0.17 | 0.12 | Upgrade
|
| Operating Expenses | 1.7 | 3.11 | 2.49 | 4.51 | 3.71 | 2.26 | Upgrade
|
| Operating Income | -1.01 | -2.06 | -1.6 | -3.8 | -3.17 | -1.67 | Upgrade
|
| Interest Expense | -0.23 | -0.89 | -0.79 | -3.31 | -0.77 | -0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.45 | -0.89 | - | -1.42 | 0.06 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -1.69 | -3.84 | -2.39 | -8.53 | -3.87 | -1.74 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 1.19 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0.01 | 0.01 | -1.07 | 0.05 | - | - | Upgrade
|
| Pretax Income | -1.68 | -2.64 | -3.47 | -8.48 | -3.87 | -1.74 | Upgrade
|
| Net Income | -1.68 | -2.64 | -3.47 | -8.48 | -3.87 | -1.74 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0 | 0 | 0.11 | 3.77 | 0.51 | - | Upgrade
|
| Net Income to Common | -1.68 | -2.64 | -3.58 | -12.25 | -4.38 | -1.74 | Upgrade
|
| Shares Outstanding (Basic) | 545 | 377 | 134 | 51 | 22 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | 545 | 377 | 134 | 51 | 22 | 17 | Upgrade
|
| Shares Change (YoY) | 78.66% | 182.36% | 161.99% | 128.66% | 32.66% | 10.60% | Upgrade
|
| EPS (Basic) | -0.00 | -0.01 | -0.03 | -0.24 | -0.20 | -0.10 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.01 | -0.03 | -0.24 | -0.20 | -0.10 | Upgrade
|
| Free Cash Flow | -0.13 | -1.57 | -0.77 | -1.19 | -1.34 | -0.28 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.06 | -0.02 | Upgrade
|
| Gross Margin | 75.08% | 77.51% | 77.28% | 78.04% | 73.66% | 71.25% | Upgrade
|
| Operating Margin | -109.62% | -153.09% | -139.46% | -418.83% | -429.11% | -201.10% | Upgrade
|
| Profit Margin | -182.41% | -196.08% | -311.03% | -1350.18% | -593.40% | -210.23% | Upgrade
|
| Free Cash Flow Margin | -14.23% | -116.18% | -67.26% | -131.56% | -181.13% | -33.84% | Upgrade
|
| EBITDA | -1.01 | -2.06 | -1.58 | -3.78 | -3.14 | -1.64 | Upgrade
|
| EBITDA Margin | -109.25% | -152.76% | -137.55% | - | - | -198.16% | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| EBIT | -1.01 | -2.06 | -1.6 | -3.8 | -3.17 | -1.67 | Upgrade
|
| EBIT Margin | -109.62% | -153.09% | -139.46% | - | - | -201.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.